Pan Lung Cancer Panel is an advanced medical test used to assess the presence of biomarkers for lung cancer. This test involves examining a range of biological and genetic factors associated with the disease, helping doctors determine the likelihood of developing cancer. It is considered an important tool for early diagnosis, as it contributes to improving treatment opportunities and success rates. The test is also used to monitor the patient's response to treatment and provide necessary information to guide therapeutic plans.